Pylori 13

7680541920109 CH-54192 Unbekannt

Associated product:

PYLORI 13 Helicobacter pylori kit de test respir
Pylori 13
Pylori 13
1 / 2
google

Article details

Package size
1
Selling units
1
Measure
Stück
Galenic form
Unbekannt
Galenic group
unbekannt

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
12/01/2022
Summary of Product Characteristics
Français
12/01/2022
Summary of Product Characteristics
Italien
12/01/2022

Detailed composition

Substance Quantity Type Category
II
2.0 G Substance HNIDK
I
100.0 MG Substance Wirkstoff (Principe actif)
I
- Substance HNIDK
I
- Substance HNIDK
I
- Substance HNIDK
I
7.0 MG Substance HBESI
I
1.117 MG Substance HBESI

Authorization holder

Curatis AG

4410 Liestal

Authorization information

Swissmedic authorization number
54192
Drug name
Pylori 13
Galenic form
TAB
ATC Code
V04CX
Authorization status
Z
Dispensing category
B
First authorization
20/10/2000
Authorization expiration date
31/12/9999
IT Number
14.03.0.
Domain
Human medicine
Field of application
in vivo Diagnose einer Helicobacter pylori Infektion des Magens und des Zwölffingerdarms

Package details

Description (FR)
PYLORI 13 Helicobacter pylori kit de test respir
Description (DE)
PYLORI 13 Helicobacter pylori Atemtest-Kit
Market launch
20/10/2000
Narcotic (BTM)
No